Literature DB >> 26087241

The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.

In-Uk Song1, Ikdong Yoo, Yong-An Chung, Jaeseung Jeong.   

Abstract

INTRODUCTION: Brain perfusion deficits have been reported previously in patients with Parkinson's disease (PD) and multiple system atrophy (MSA). However, clinical differential diagnosis between mildly symptomatic PD and the Parkinson's variant of MSA (MSA-P) is difficult because of the similarity of symptoms between parkinsonian disorders. Accurate diagnosis of these disorders is important for treatment decisions, appropriate advice, management, and prognosis. Therefore, we conducted this study to investigate the difference in perfusion single-photon emission computed tomography (SPECT) between patients with mild symptomatology of PD and those with MSA-P using the SPM program. PATIENTS AND METHODS: We consecutively recruited 47 patients with PD, 21 patients with MSA-P, and 48 age-matched healthy controls. All participants underwent Tc-99m hexamethylpropyleneamine oxime (HMPAO) perfusion SPECT, and the perfusion images were analyzed.
RESULTS: Perfusion SPECT showed hypoperfusion in the frontal cortex in both PD and MSA-P patients compared with healthy controls. Hypoperfusion in the occipital cortex was seen only in PD patients. There are no significant intercorrelations of blood flow in the cerebral region between PD and MSA-P patients.
CONCLUSION: We cautiously assume that the only difference in cerebral blood perfusion images of mild symptomatic PD and MSA-P patients is blood perfusion in the occipital cortex. Although there are many cerebral regions with similar perfusion in patients with PD and MSA-P of mild symptomatology, we could assume that each has a completely different pathophysiology for PD and MSA-P because of the lack of significant intercorrelation of blood flow in the cerebral region.

Entities:  

Mesh:

Year:  2015        PMID: 26087241     DOI: 10.1097/MNM.0000000000000354

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

Review 1.  Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Authors:  Usman Saeed; Jordana Compagnone; Richard I Aviv; Antonio P Strafella; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Transl Neurodegener       Date:  2017-03-28       Impact factor: 8.014

2.  Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy.

Authors:  Piotr Alster; Michał Nieciecki; Dariusz M Koziorowski; Andrzej Cacko; Ingeborga Charzyńska; Leszek Królicki; Andrzej Friedman
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 3.  Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Usman Saeed; Anthony E Lang; Mario Masellis
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

4.  Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's Disease patients assessed using pseudo-continuous arterial spin labeling.

Authors:  Yufen Chen; Peter Pressman; Tanya Simuni; Todd B Parrish; Darren R Gitelman
Journal:  PeerJ       Date:  2015-11-03       Impact factor: 2.984

5.  The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.

Authors:  Huan-Jie Huang; Xing-Yu Zhu; Xun Wang; Zhang-Yang Wang; Wan-Li Zhang; Bi-Cheng Chen; Chun-Feng Liu
Journal:  Front Neurol       Date:  2018-01-05       Impact factor: 4.003

6.  Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated.

Authors:  Young-Sil An; Jung Han Yoon; Sang Joon Son; Chang Hyung Hong; Su Jin Lee; Joon-Kee Yoon
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.